0 Commentaires
0 Parts
3KB Vue
0 Aperçu
Rechercher
Découvrez de nouvelles personnes, créer de nouvelles connexions et faire de nouveaux amis
-
Connectez-vous pour aimer, partager et commenter!
-
Global Drug Discovery Outsourcing Market Size, Share, Key Drivers, Growth Opportunities and Global Trends 2032The global Drug Discovery Outsourcing Market is expected to reach USD 7.20 Biliion by the end of 2032, with a valuation of USD 3.79 Biliion in 2023, according to a report released by Zion Market Research. Over the course of the projected period, the market is anticipated to expand at a CAGR of 7.4%. The study examines the factors driving and limiting the global Drug Discovery Outsourcing...0 Commentaires 0 Parts 3KB Vue 0 Aperçu
-
Unlocking Large Molecule Drug Discovery Outsourcing Market Potential: Future Trends, Growth Drivers, and InsightsIn its latest publication, Polaris Market Research presents an in-depth analysis of the Large Molecule Drug Discovery Outsourcing Market. It captures the segmentation-driven shifts defining growth opportunities, competitive dynamics, and solution development within the industry. This comprehensive report combines historical data, real-time analytics, and forward-looking projections to...0 Commentaires 0 Parts 744 Vue 0 Aperçu
-
Mergers, Acquisitions, and Capacity Expansion: How CROs Are Scaling for Global DemandThe global small molecule drug discovery outsourcing market, valued at USD 4.48 billion in 2024, is projected to grow at a compound annual growth rate (CAGR) of 9.68% from 2025 to 2034, driven by rising R&D costs, talent shortages, and the pharmaceutical industry’s strategic pivot toward external innovation. This growth is not uniform across geographies, as regional disparities in...0 Commentaires 0 Parts 1KB Vue 0 Aperçu
-
Mergers, Acquisitions, and Expansion: How Global CROs Are Strengthening U.S. OperationsThe U.S. small molecule drug discovery outsourcing market, valued at USD 1.49 billion in 2024, is anticipated to expand at a CAGR of 9.48% from 2025 to 2034, with growth increasingly driven by segment-wise performance across service types, therapeutic areas, and technological platforms. Unlike biologics development, which relies on biological systems, small molecule discovery remains rooted in...0 Commentaires 0 Parts 1KB Vue 0 Aperçu
Commandité